InvestorsObserver
What We Do
Reviews
About Us
Pricing
Sign Up
Home
My Portfolio
Stocks
Options
Crypto
Calendars
Compare
News
My Watchlists
Help Center
Pricing
What We Do
Reviews
About Us
News Home

Eli Lilly Says FDA OKs Jardiance for Kidney Disease

Last Updated: Friday, September 22, 2023 9:38 AM | Bobby Raines

Morning News Leader

Eli Lilly (LLY) and Boehringer Ingelheim said teh FDA approved Jardiance for adults with kidney disease.

InvestorsKeyhole Trade Alert

Share this article:

Related Companies

You May Also Like

Related Articles

Is Abbott Laboratories (ABT) Stock Trading Below Fair Value?

Tuesday, November 28, 2023, 3:56 PM | InvestorsObserver Analysts

Zimmer Biomet Holdings Inc (ZBH) Stock Is Higher By 0.44% This Week: Buy, Hold, or Sell?

Tuesday, November 28, 2023, 3:43 PM | InvestorsObserver Analysts

Will Align Technology, Inc. (ALGN) Stay at the Bottom of the Healthcare Sector?

Tuesday, November 28, 2023, 3:42 PM | InvestorsObserver Analysts

How Will the Market React to Baxter International Inc (BAX) Stock Getting a Bullish Rating

Tuesday, November 28, 2023, 3:39 PM | InvestorsObserver Analysts

Where Will Henry Schein, Inc. (HSIC) Stock Go Next After It Is Down 1.65% in a Week?

Tuesday, November 28, 2023, 3:39 PM | InvestorsObserver Analysts

Is Steris PLC (STE) a Leader in the Healthcare Sector?

Tuesday, November 28, 2023, 3:30 PM | InvestorsObserver Analysts

Related Companies